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Abstract
The majority of nucleotide binding domain leucine rich repeats-containing (NLR) family members has yet to be functionally
characterized. Of the described NLRs, most are considered to be proinflammatory and facilitate IL-1b production. However,
a newly defined sub-group of NLRs that function as negative regulators of inflammation have been identified based on their
abilities to attenuate NF-kB signaling. NLRP12 (Monarch-1) is a prototypical member of this sub-group that negatively
regulates both canonical and noncanonical NF-kB signaling in biochemical assays and in colitis and colon cancer models.
The role of NLRP12 in infectious diseases has not been extensively studied. Here, we characterized the innate immune
response of Nlrp122/2 mice following airway exposure to LPS, Klebsiella pneumoniae and Mycobacterium tuberculosis. In
response to E. coli LPS, Nlrp122/2 mice showed a slight decrease in IL-1b and increase in IL-6 production, but these levels
were not statistically significant. During K. pneumoniae infection, we observed subtle differences in cytokine levels and
significantly reduced numbers of monocytes and lymphocytes in Nlrp122/2 mice. However, the physiological relevance of
these findings is unclear as no overt differences in the development of lung disease were observed in the Nlrp122/2 mice.
Likewise, Nlrp122/2 mice demonstrated pathologies similar to those observed in the wild type mice following M.
tuberculosis infection. Together, these data suggest that NLRP12 does not significantly contribute to the in vivo host innate
immune response to LPS stimulation, Klebsiella pneumonia infection or Mycobacterium tuberculosis.
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Introduction
Initiation and termination of the host innate immune response
to pathogenic bacteria infection is tightly regulated. The host
response to respiratory bacteria is initially driven through the
stimulation of TLRs. TLR activation signals through the NF-kB
pathway to up-regulate the transcription of proinflammatory
cytokines, including IL-1b, TNFa, and IL-6, which are essential
for the recruitment of leukocytes to the lung and clearance of the
infection. Mice deficient in these three proinflammatory cytokines
have demonstrated significant increases in morbidity and mortality
during respiratory infections with Klebsiella pneumoniae and Myco-
bacterium tuberculosis [1,2].
While TLR recognition occurs on the plasma membrane and in
endosomes, the nucleotide binding domain leucine rich repeats-
containing family of proteins (NLRs) are a second family of
pathogen recognition receptors (PRRs) that sense intracellular
danger associated molecular patterns (DAMPs) and pathogen
associated molecular patterns (PAMPs) in the cell cytoplasm
[3,4,5,6]. Thus far, over 23 distinct NLRs have been identified;
however, the biological functions of the majority of these proteins
have yet to be elucidated. The bulk of NLR publications have
sought to characterize a sub-group of NLRs that function in the
formation of a multi-protein complex termed the inflammasome,
which includes a specific NLR, the adaptor protein PYCARD and
Caspase-1. An inflammasome forms following the activation of a
particular NLR by a specific danger signal, which ultimately
results in the activation of caspase-1 and the subsequent post-
translational cleavage of pro-IL-1b and pro-IL-18 into their active
forms.
Unlike the majority of characterized proinflammatory NLRs,
recent studies have identified a novel sub-group of NLRs that have
the ability to attenuate inflammation [7,8,9,10,11,12,13]. The
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exact mechanism underlying this negative regulation is an area of
active investigation; however, it appears that most of these NLRs
function by inhibiting components of NF-kB signaling. The NLR,
NLRP12 (formally known as MONARCH-1 or PYPAF7), is a
prototypical member of this sub-group that functions as a negative
regulator of the immune system through the attenuation of non-
canonical NF-kB signaling and p52-dependent chemokine expres-
sion [12,14]. This suppression is facilitated by the association of
NLRP12 with the proteasome and the subsequent proteasome-
dependent degradation of NF-kB inducing kinase (NIK) [12]. The
interaction of NLRP12 with components of the NF-kB pathway
ultimately results in the attenuated production of proinflammatory
cytokines following PAMP stimulation and bacterial infections. In
vivo, NLRP12 has been shown to dramatically influence the
development of contact hypersensitivity, gastrointestinal inflam-
mation and tumorigenesis [14,15,16].
Bacterial mediated infectious lung diseases are an important
worldwide cause of morbidity and mortality. The gram negative
bacterium Klebsiella pneumoniae is a leading cause of community-
and hospital-acquired respiratory infection. The growing preva-
lence of antibiotic resistant strains constitutes a serious public
health concern [17]. Pathogenic K. pneumoniae is capable of
inducing severe bacterial pneumonia that is characterized by
extensive lung inflammation, hemorrhage and necrotic lesion
formation in the lungs, which can often progress to bacteremia
and sepsis [18]. Similar to K. pneumoniae, the incidence of
Mycobacterium tuberculosis (Mtb) is also a global threat based on the
increasing prevalence of antibiotic resistant Mtb [19,20]. One third
of the world’s population is infected with Mtb and tuberculosis is
associated with 1.4 million deaths per year [20]. The majority of
patients infected with Mtb develop a latent tuberculosis infection.
Individuals that are latently infected with Mtb will maintain a
significant lifetime risk of disease reactivation despite being
asymptomatic [20]. Disease reactivation is typically associated
with some level of immune system compromise, such as HIV co-
infection, or as a consequence of immunosuppressive drug therapy
[21]. Thus, a deeper understanding of the underlying immune
mechanisms that regulate active and latent Mtb infection is of
immense clinical importance.
The innate immune response to K. pneumoniae and Mtb is
influenced by NLR family members. Components of the NLRP3
inflammasome directly mediate the ex vivo and in vitro production
of pro-inflammatory cytokines in response to K. pneumoniae
infection in primary macrophages and monocytic cell lines [1].
Likewise, NLRP3 inflammasome components are essential for host
defense against K. pneumoniae in vivo through the regulation of IL-1b
production and necrosis in the lungs [1]. Components of the
NLRP3 inflammasome are also essential for the production of
active IL-1b in cultured human monocytes and primary mouse
macrophages infected with Mtb. In addition, the NLR inflamma-
some adaptor protein PYCARD (ASC) exerts a novel NLRP3-
independent role in granuloma formation and maintenance during
in vivo Mtb infection [22]. Other NLRs, including NLRP12, have
also been evaluated in the host immune response to gram negative
bacteria and Mtb in vitro. Studies in the THP-1 human monocytic
cell line found that Nlrp12 is highly expressed at baseline levels,
and expression is down-regulated following stimulation with TNF-
a, IFN-c, or Mtb [10]. Downregulation of NLRP12 was suggested
to be an important step in allowing the host to mount an effective
inflammatory response [10]. Functionally, shRNA knockdown of
NLRP12 results in increased levels of pro-inflammatory cytokines
following LPS or Mtb challenge [10]. However, these studies were
performed in vitro with human cell lines that express high basal
levels of NLRP12; thus, validation in a more physiologically
relevant setting is necessary. While several studies have assessed
the contribution of proinflammatory NLRs in host defense, few
studies have explored the in vivo role of the NLR family members
that exert negative regulatory activities in host defense against
pathogenic bacteria.
The identification and in vivo characterization of proteins that
function as negative regulators of inflammation is an area of
intense scientific and clinical importance for the development of
clinical therapies. Previous studies have shown that NLRP12
functions as a negative regulator of inflammatory pathways in vitro;
however, the role of NLRP12 in regulating host-pathogen
interactions in vivo is not well defined. Here, we tested the
hypothesis that mice lacking Nlrp12 would demonstrate increased
morbidity, mortality and pathology following in vivo K. pneumoniae
or Mtb infection. Based on the previous in vitro findings, we
expected to observe accelerated disease progression, lung inflam-
mation and cytokine production associated with an overzealous




All studies were conducted under the approval of the
Institutional Care and Use Committee (IACUC) for The
University of North Carolina at Chapel Hill and in accordance
with the National Institutes of Health Guide for the Care and Use
of Laboratory Animals. Nlrp122/2 animals were kindly provided
by Millennium Inc. and previously described [15]. All mice were
maintained under specific pathogen free conditions and all
experiments were performed with 6–12 week old age- and sex-
matched mice. All mice were backcrossed onto C57Bl/6J for a
minimum of 12 generations. Nlrp122/2 mice were compared to
both purchased C57Bl/6J mice and littermate control mice from
heterozygous breeding. All in vivo Mtb work was conducted under
approved BSL-3/ABSL-3 protocols and conditions.
Evaluation of Cytokine Levels in Primary Dendritic Cells
Wild type and Nlrp122/2 dendritic cells were isolated and
cultured as previously described [14]. Once matured, the dendritic
cells were stimulated with either 50 ng/ml of E. coli 0111:B4 LPS
(Invivogen), 50 ng/ml of Klebsiella pneumoniae LPS (Sigma; source
strain is ATCC 15380) or 50 mg/ml of trehalose-6,6-dibehenate
(TDB), which is a synthetic analog of trehalose-6,6-dimycolate
from Mycobacterium tuberculosis (Invivogen). Cell culture superna-
tants were collected following 4 hours of stimulation and TNF-a,
IL-6 and IL-1b levels were assessed using ELISA (BD Biosciences).
To evaluate IL-1b maturation and release, cells were treated with
2 mM ATP for 30 minutes prior to harvesting the supernatants.
Pro- and cleaved IL-1b was detected by western blot in dendritic
cell lysate and supernatant following 24 hours of LPS stimulation.
Following the supernatant harvest, the remaining cells were lysed
in 1% RIPA buffer. Immunoblots were probed with goat anti-
mouse IL-1b primary antibody (R&D Biosystems), followed by
rabbit anti-mouse HRP secondary antibody (Santa Cruz). Bands
were visualized by Super Signal Chemiluminescence (Pierce).
Induction and Assessment of Acute Airway Inflammation
To assess lipopolysaccharide (LPS) induced acute airway
inflammation, isoflurane inhalation was used to anesthetize the
mice, and LPS (Sigma) isolated from Escherichia coli (sterile serotype
0111:B4) was instilled via intratracheal (i.t.) administration as
previously described [23]. Control animals received an i.t. dose of
NLRP12 and Infectious Pulmonary Disease
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saline. Mice were euthanized and airway inflammation was
assessed 48 hours post LPS exposure.
Bacterial mediated acute airway inflammation was induced by
K. pneumoniae lung challenge. K. pneumoniae 43816 (serotype 2) was
obtained from the ATCC and cultured under suppliers recom-
mended conditions. Prior to each experiment, bacteria density was
estimated by measuring the absorbance at 600 nm and actual
colony forming units (CFUs) were determined by plating an
aliquot on LB agar plates. Mice were challenged via i.t. instillation
with either 7.46104 CFUs of K. pneumoniae in 50 ml of PBS or PBS
alone (mock), as previously described [1]. To assess in vivo bacteria
burden, mice were euthanized via i.p. injection with 2,2,2
tribromoethanol (avertin), bronchoalveolar lavage fluid (BALF)
was collected as described below, and the cell free fluid was serially
diluted and plated on LB agar plates. Additionally, the liver was
removed, wet weight assessed, homogenized in 500 ml of HBSS
with a Tissue Master 125 (Omni International) and centrifuged.
The resulting supernatants were plated on LB agar plates.
Whole Body Aerosol Infection with Mycobacterium
tuberculosis
Mycobacterium tuberculosis H37Rv strain was obtained from the
American Type Culture Collection (ATCC). Bacteria were grown
to log phase in Middlebrook 7H9 broth (Difco) with 0.2% glycerol,
16 albumin dextrose saline (ADS), and 0.05% Tween 80.
Inoculum was assessed by plating infection media on Middlebrook
7H10 agar plates supplemented with glycerol and ADS. CFUs
were counted after 21 days of incubation.
For in vivo airway infection, Nlrp122/2 and wild type mice were
infected via aerosol as previously described [24]. Mice received
250–350 CFUs per lung, which was determined by sacrificing a
subset of mice 1 day post infection as previously described [24].
Bacterial organ burden was quantified by plating serial dilutions of
lung, liver, and spleen homogenates on 7H10 agar containing
cycloheximide (1 mg/ml) and carbenicillin (50 mg/ml) to minimize
contamination. CFUs were counted after 21 days of incubation
and again after 35 days of incubation. All animal infections and
organ harvests were carried out under BSL3/ABSL3 conditions.
Evaluation of Airway Inflammation
Upon completion of the LPS and K. pneumoniae models, mice
were euthanized and serum was collected from animals by cardiac
puncture. Bronchoalveolar lavage fluid (BALF) was collected to
evaluate leukocytes and cytokine levels. The lungs were lavaged
three times with 1 ml of HBSS. Following centrifugation, the
cytokine levels in the cell free supernatants were evaluated by
ELISA (BD Biosciences). Total BALF cellularity was determined
from the resuspended cell pellet and evaluated using a hemocy-
tometer. The composition of the BALF was determined by
evaluating the morphology of $200 cells per sample following
differential staining (Diff-Quik, Dade Behring) of cells that were
cytospun onto slides.
At specific time points post-Mtb infection, mice were euthanized
and the liver, spleen and right lung lobes were collected and
homogenized for bacteria CFU analysis and cytokine profiles.
Tissue homogenates were serial diluted and plated to determine
CFUs. The remaining lung homogenates were centrifuged to
remove cellular debris and the supernatant was double filter
sterilized for cytokine analysis by ELISA.
For LPS and K. pneumoniae histopathology, whole lungs were
fixed by inflation to 20-cm pressure and immersion in 10%
buffered formalin. To evaluate Mtb histopathology, the left lung
lobe was removed, manually inflated and immersed in buffered
formalin. Inflammation was evaluated in sections (5 mm) of the left
lung lobe, following hematoxylin and eosin (H&E) staining.
Paraffin embedded sections were set and cut to reveal the
maximum longitudinal visualization of the intrapulmonary main
axial airway. Histopathology was evaluated and scored by blinded
reviewers on a scale of 0 (absent) to 3 (severe), as previously
described [1,23,25]. The parameters assessed included overall
leukocyte infiltrations, perivascular and peribroncheolar cuffing,
airway epithelial cell injury, extravasation, and the estimated
percent of lung area involved with inflammation. Each individual
parameter was scored and averaged to generate the histology
score. Additional parameters were used to evaluate the granulo-
mas in the Mtb histopathology as previously described [22].
Briefly, granuloma frequency was measured by counting the
number of granulomas present in the total lung section, and
granuloma size was evaluated using Image J software after the
granuloma borders were defined. Ziehl-Neelsen (ZN) staining was
utilized to evaluate acid fast bacterial localization within the lung
and granuloma as previously described [22].
Statistical Analysis
We utilized GraphPad Prism 5 Statistical software to conduct
Analysis Of Variance (ANOVA) followed by either Tukey-Kramer
HSD or Newman-Keuls post-test to evaluate statistical significance
for multiple comparisons. Single data point comparisons were
evaluated by the Student’s two-tailed t-test. All data are presented
as the mean +/2 the standard error of the mean (SEM), and in all
cases a p-value of less than 0.05 was considered statistically
significant.
Results
NLRP12 Attenuates the Release of TNFa and IL-6 in Bone
Marrow Derived Dendritic Cells, but does not Contribute
to IL-1b Maturation or Release
Previous studies characterizing NLRP12 in human monocyte
cell lines revealed that NLRP12 functions as a negative regulator
of NF-kB signaling following stimulation with TLR agonist, TNFa
and infection with M. tuberculosis [10,12]. To expand upon these
previous findings, we sought to evaluate the contribution of
NLRP12 in mediating the host immune response in mice. Initially,
we utilized bioinformatics to evaluate Nlrp12 expression patterns in
specific cell subpopulations. Nlrp12 expression in mouse cells
associated with the host immune response was compiled using a
publically accessible microarray meta-analysis search engine
(Nextbio website. Available: http://www.nextbio.com/b/search/
ba.nb. Accessed 2013 March 11), as previously described [14].
This analysis revealed highly variable levels in the expression of
Nlrp12 in select cell populations relevant to the host immune
response. Nlrp12 was found to be highly expressed in neutrophils
and consistently expressed in dendritic cell populations
(Figure 1A). However, macrophage Nlrp12 expression was highly
variable. For example, cell populations from the spleen expressed
high levels of Nlrp12, whereas populations from the peritoneal
cavity did not have any detectable levels (Figure 1A). To evaluate
cytokine production in response to pathogen stimulation, dendritic
cells were isolated from the bone marrow, cultured and matured as
previously described [14]. These primary cells were stimulated
with pathogen associated molecular patterns (PAMPs) associated
with E. coli, K. pneumoniae and M. tuberculosis infection. TNFa levels
were significantly increased in Nlrp122/2 dendritic cell cultures
following stimulation with E. coli derived LPS, K. pneumoniae
derived LPS and the M. tuberculosis PAMP TDB (Figure 1B).
Similarly, IL-6 levels were also significantly increased in Nlrp122/2
isolated cells stimulated with E. coli LPS and TDP (Figure 1B).
NLRP12 and Infectious Pulmonary Disease
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Figure 1. Dendritic cell stimulation with PAMPs associated with E. coli, K. pneumoniae and M. tuberculosis. A) Nlrp12 expression in
relevant immune system cell types was compiled using a publically accessible microarray meta-analysis search engine (Nextbio website. Available:
http://www.nextbio.com/b/search/ba.nb. Accessed 2013 March 11). B) Primary bone marrow derived dendritic cells were isolated, cultured and
stimulated with either E. coli LPS (LPS)(50 ng/ml), K. pneumoniae LPS (kpLPS)(50 ng/ml) or trehalose-6,6-dibehenate (TDB; a synthetic analog of TDM
from M. tuberculosis)(50 mg/ml). The levels of TNFa and IL-6 were evaluated in the supernatants following 4 hours of stimulation. Experiments were
NLRP12 and Infectious Pulmonary Disease
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Together, these data are consistent with previously published
findings that suggest NLRP12 functions as a negative regulator of
inflammatory signaling [10,12,14].
NLRP12 has been suggested to be capable of inflammasome
formation and facilitate IL-1b maturation [26,27]. Thus, in
addition to evaluating TNFa and IL-6, we also evaluated IL-1b
production and maturation using ELISA and western blot. We
detected a significant increase in IL-1b release into the superna-
tant by ELISA following stimulation with all three PAMPs and
ATP, in both Nlrp122/2 and wild type cells (Figure 1C).
However, no significant differences were detected in IL-1b levels
between the wild type and Nlrp122/2 cells (Figure 1C).
Moreover, western blot analysis revealed that a significant amount
of pro-IL-1b was present in the lysate from both wild type and
Nlrp122/2 cells treated with LPS (Figure 1D). Likewise, both pro-
and cleaved-IL-1b was consistently detected in the supernatant
from wild type and Nlrp122/2 dendritic cells. Thus, these findings
indicate that NLRP12 does not function in IL-1b maturation in
mouse bone marrow derived dendritic cells following stimulation
with the PAMPs tested. These data are consistent with other
published findings that failed to support a role for NLRP12 in
inflammasome formation under similar experimental conditions as
those tested here [15].
NLRP12 does not Play a Role in LPS Mediated Acute Lung
Inflammation
Lipopolysaccharide (LPS) is a component of the cell wall of
gram-negative bacteria and is ubiquitous in the environment.
Inhalation of LPS has been shown to exacerbate airway reactivity
in human asthmatics and activates the host innate immune system
by acting as a PAMP to stimulate TLR4 receptors [28]. NLRP12
has previously been shown, in vitro, to down-regulate LPS induced
NF-kB activation in human monocytes. This occurs through a
mechanism that involves the inhibition of TLR/IL-1 receptor
signaling proteins (MyD88, IRAK-1 and TRAF6) and the
hyperphosphorylation of IRAK-1 [10]. These data suggest that
NLRP12 may also function to down regulate the host innate
immune response to LPS in a model of acute airway inflammation.
Nlrp122/2 and wild type mice were challenged with 50 mg of LPS
through intratracheal (i.t.) administration and harvested 16–20 hrs
post-administration. The LPS challenge resulted in a significant
increase in total bronchoalveolar lavage fluid (BALF) cellularity,
which was consistent with a significant increase in airway
neutrophilia following LPS treatment (Figure 2A). However, no
significant differences were observed between Nlrp122/2 and wild
type mice in either the total number or composition of the
leukocyte populations present in the BALF (Figure 2B). This
suggests that airway inflammation occurs independent of NLRP12
following LPS treatment.
Airway LPS exposure results in neutrophil infiltration of the
lung parenchyma. Previous ex vivo data demonstrated that primary
dendritic cells and neutrophils isolated from Nlrp122/2 mice
displayed significantly attenuated cell migration in a model of skin
hypersensitivity [15]. While BALF cellularity is a widely accepted
and accurate surrogate marker for airway inflammation, it does
not always fully reflect the extent of inflammation in the lung
parenchyma. To further evaluate inflammation, lung histopathol-
ogy was evaluated from the main bronchi of the left lobe and
representative sections were examined (Figure 2C). Lung
histopathology assessments revealed that LPS induced a significant
increase in infiltrating neutrophils in the areas around the lung
vasculature (perivascular), the lung parenchyma, and the large and
small airways (peribronchiolar) (Figure 2C). However, no
significant differences were observed in the lung histopathology
between LPS challenged Nlrp122/2 and wild type mice
(Figure 2D). Together, the BALF cellularity assessments and
the histopathology findings show that NLRP12 does not play a
significant role in LPS-induced acute lung inflammation.
Previous in vitro studies have demonstrated that NLRP12
functions as a negative regulator of TNFa signaling and the
LPS-induced production of IL-6 and IL-1b in human monocyte
cell lines [10]. However, the in vitro role of NLRP12 appears to be
cell type and species specific. Studies utilizing ex vivo primary cells
from Nlrp122/2 mice indicate that NLRP12 does not appear to
influence the production of TNFa, IL-6 or IL-1b in mouse bone
marrow derived dendritic cells [14,15]. Thus, we sought to
evaluate the in vivo contribution of NLRP12 in the local (BALF)
and systemic (serum) cytokine response following airway admin-
istration of LPS (Figure 2E–F). We observed a significant
increase in TNFa, IL-1b and IL-6 in the BALF following LPS
challenge in both Nlrp122/2 and wild type mice (Figure 2E).
Likewise, LPS challenge increased the serum levels of IL-1b and
IL-6 (Figure 2F). TNFa was not detected in the serum following
LPS challenge (data not shown). NLRP12 has been shown to
associate with the inflammasome adaptor protein ASC/PY-
CARD, which suggests that NLRP12 may be capable of
inflammasome formation under certain conditions [26,27]. As
seen in Figure 2E and F, BALF IL-1b levels were consistently
attenuated and serum IL-6 levels were consistently increased in the
Nlrp122/2 mice following LPS administration. However, these
results did not achieve statistical significance. No other significant
differences were observed in cytokine levels between the Nlrp122/
2 and wild type mice (Figure 2E–F).
Mice Lacking Nlrp12 Demonstrate Normal Immune
Responses following Klebsiella pneumoniae Airway
Infection
The use of bacterial LPS to induce acute lung inflammation is a
well established and highly advantageous model that is commonly
employed to assess the effects of Gram-negative bacteria.
However, live bacterial pathogens activate the host innate immune
system through a diverse range of PAMPs, effector proteins and
antimicrobial peptides. Thus, one of the often cited limitations of
LPS based models is that endotoxin exposure provides a limited
view of the actual events that occur during a live bacteria infection
in the lungs [29]. Several NLR proteins play integral roles in
mediating the host innate immune response to a variety of lung
pathogens. For example, NLRP3 is critical to the host immune
response following airway infections with Klebsiella pneumoniae and
Chlamydia pneumoniae [1,30]. NLRC4 plays a vital role in regulating
IL-1b and IL-18 production during lung mucosal defense
following infections with Pseudomonas aeruginosa and Burkholderia
repeated at least 3 separate times with dendritic cells harvested from 3 individual mice for each genotype and treatment in each replicate. C) IL-1b
was evaluated in the supernatants 4 hours after stimulation, following an additional treatment with 2 mM ATP 30 minutes prior to harvesting the
supernatants. Experiments were repeated at least 3 separate times with dendritic cells harvested from 3 individual mice for each genotype and
treatment in each replicate. D) Pro- and cleaved IL-1b was detected by western blot in dendritic cell lysate and supernatant following LPS stimulation.
Experiments were repeated at least 3 separate times with dendritic cells harvested and pooled from 3 individual mice from each genotype and
treatment in each replicate.
doi:10.1371/journal.pone.0060842.g001
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Figure 2. LPS mediated acute airway inflammation in Nlrp122/2 mice. Mice were challenged with 1 mg/kg of E. coli LPS (serotype 0111:B4) i.t.
and airway inflammation was assessed 48 hours post-challenge. A) LPS induced a significant increase in BALF cellularity. B) No significant differences
were detected in the cellular composition of the BALF between Nlrp122/2 and wild type mice. C) Airway challenge with LPS resulted in a significant
influx of neutrophils to the airway. Histopathology revealed a significant amount of perivascular and peribroncholar cuffing and some slight alveolar
occlusion following lung LPS exposure. The magnification bar at 106= 10 mM and 406= 5 mM. D) Histopathology analysis and histology scoring
revealed no significant differences between the Nlrp122/2 and wild type mice. E–F) LPS induced a significant increase in local (BALF) and systemic
(serum) levels of proinflammatory cytokines. No significant differences were observed between Nlrp122/2 and wild type mice. Saline, n = 3; LPS-
treated Nlrp122/2, n = 6; LPS-treated Wild Type, n = 6. Experiments were repeated 3 separate times with the same numbers of mice in each replicate.
doi:10.1371/journal.pone.0060842.g002
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Figure 3. The host innate immune response to Klebsiella pneumoniae infection in Nlrp122/2 mice. A) Body temperature was monitored
daily to assess morbidity. K.pneumoniae infection induced a significant decrease in body temperature in both Nlrp122/2 and wild type mice. B) The
lungs were lavaged with HBSS and total BALF cellularity was determined. C) No significant differences in were observed in the BALF neutrophil
populations between Nlrp122/2 and wild type mice. However, a significant decrease in the number of monocytes (p = 0.042) and lymphocytes
(p = 0.032) were observed in the BALF from the Nlrp122/2 mice compared to the wild type. *P,0.05. D) No differences in bacterial burden were
found between the BALF and livers of Nlrp122/2 and wild type animals. E) Histopathology revealed a significant amount of alveolar occlusion
following K. pneumoniae infection in both Nlrp122/2 and wild type mice. The magnification bar at 106= 10 mM and 406= 5 mM. F) Histology scoring
confirmed that no significant differences were identified between the Nlrp122/2 and wild type mice. G) A significant increase in TNFa, IL-6 and IL-1b
was observed in the BALF from all K. pneumoniae challenged animals. Saline, n = 3; Nlrp122/2, n = 13; Wild Type, n = 15. Experiments were repeated 3
separate times with a minimum of 7 K. pneumoniae infected Nlrp122/2 and 7 wild type mice in each group. n.s. = not significant; p = 0.0917.
doi:10.1371/journal.pone.0060842.g003
NLRP12 and Infectious Pulmonary Disease
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pseudomallei [31,32]. Likewise, the non-inflammasome forming
NLR, NLRC2/NOD2, plays a role in neutrophil recruitment and
bacterial killing during E. coli-mediated pneumonia in mice [33].
Thus, we next sought to determine if the host innate immune
response is significantly altered in Nlrp122/2 mice during a live
bacterial lung infection with K. pneumoniae.
The local administration of K. pneumoniae to the lungs results in
significant morbidity, mortality, pneumonia and systemic mani-
festations of sepsis [1]. Nlrp122/2 mice were challenged via i.t.
installation with 7.46104 CFUs of K. pneumoniae. Previous studies
have shown that disease progression peaks at 48 hrs post-infection
in wild type C57Bl/6 mice in this K. pneumoniae model [1]. To
assess the clinical manifestations of disease progression, body
temperature was utilized as a highly sensitive surrogate marker for
disease progression. As shown in Figure 3A, 48 hrs after K.
pneumoniae exposure, infected animals demonstrated a significant
decrease in body temperature. However, no significant differences
were detected between Nlrp122/2 and wild type animals
(Figure 3A). Airway inflammation was assessed by BALF
cellularity, which revealed a significant increase in total cellularity
following K. pneumoniae infection (Figure 3B). Additional mor-
phological analysis of the BALF cellularity revealed that the
increase in cellularity was associated with a significant influx of
neutrophils (Figure 3C). Notably, Nlrp122/2 mice exhibited
significantly reduced levels of monocytes and lymphocytes
compared to wild type mice. However, the overall significance
of the reduced numbers of these specific cell populations in the K.
pneumoniae model is unknown as global disease progression was
unaffected. Local and systemic bacteria burdens can dramatically
influence the host innate immune response and typically reflect
disease progression. To measure the bacteria load, BALF was
collected and livers were harvested from mice 48 hrs after K.
pneumoniae infection. Similar amounts of bacteria were observed in
the lungs and livers of Nlrp122/2 and wild type mice, and no
significant differences in bacteria burden were observed between
Nlrp122/2 and wild type animals (Figure 3D). This indicates that
NLRP12 does not influence K. pneumoniae clearance or dissemina-
tion in this acute lung infection model.
K. pneumoniae infection is characterized by the development of
severe pneumonia and parenchymal disease. Thus, to determine if
histopathology was significantly altered in Nlrp122/2 mice, lungs
were harvested 48 hrs post-infection and histopathology was
evaluated. As expected, all of the mice challenged with K.
pneumoniae showed significantly increased inflammatory cell infil-
tration and extensive alveolar space occlusion (Figure 3E).
Subsequent histological scoring revealed that there were no
significant differences in lung histopathology between Nlrp122/2
and wild type animals (Figure 3F). Together, these data suggest
that NLRP12 deficiency does not alter the clinical progression of
K. pneumoniae infection in mice.
In addition to inducing robust airway inflammation, K.
pneumoniae infection also induces the local and systemic production
of several cytokines that have been previously associated with
NLRP12 function [1]. As shown in Figure 3G, airway challenges
with K. pneumoniae induced a significant increase in BALF TNFa,
IL-6 and IL-1b levels. In the case of TNFa, we consistently
observed a trend towards attenuated levels in the Nlrp122/2 mice;
however, the levels of TNFa were never found to be significantly
different between the Nlrp122/2 and wild type animals
(Figure 3G). Likewise, no statistically significant differences were
detected in BALF IL-6 or IL-1b between the wild type and
Nlrp122/2 mice (Figure 3G). Together, these data suggest that
NLRP12 does not play a substantial role in regulating the
production of several critical cytokines in response to K. pneumoniae
airway infection.
NLRP12 does not Play a Role in the in vivo Host Immune
Response to Mycobacterium tuberculosis Infection
In contrast to the acute lung infection caused by K. pneumoniae,
Mycobacterium tuberculosis (Mtb) is a chronic lung pathogen. Previous
data obtained from an Mtb infected human macrophage line
indicates that proinflammatory cytokine levels are increased in the
absence of NLRP12 [10]. These data demonstrate that NLRP12 is
important for dampening the host immune response during Mtb
infection. Thus, we tested if the absence of NLRP12 would cause
an overzealous host immune response leading to increased
morbidity, mortality and lung inflammation during in vivo Mtb
infection.
Nlrp122/2 and wild type mice were infected with Mtb via
aerosol infection. We found that the mean survival was 217 days
post-infection for Nlrp122/2 mice and 220 days for wild type mice
(Figure 4A). We did not observe any differences in morbidity or
mortality between the Nlrp122/2 and wild type animals, indicating
that NLRP12 does not play a prominent role in host protection
during Mtb infection. In addition to survival, we also sought to
determine if NLRP12 has an effect on bacterial growth during
in vivo infection by measuring the bacterial burden within the lungs
at various time points post-infection. The lungs of Nlrp122/2 and
wild type mice were harvested at 1, 14, 26 and 177 days post-
infection to evaluate bacterial burden and cytokines following Mtb
infection. We did not observe any differences in the amount of Mtb
present within the lungs of Nlrp122/2 or wild type mice at any
time point post-infection (Figure 4B). In addition to the local
bacteria burden, we also measured the ability of Mtb to
disseminate to secondary sites of infection. Bacterial dissemination
to the liver and spleen occurs by 14 days post-infection in wild
type C57Bl/6 mice [22]. We found no differences between the
bacterial burden of the liver and spleen when we compared
Nlrp122/2 and wild type animals (Figure 4C–D). These results
indicate that NLRP12 does not influence Mtb growth or
dissemination at either the primary or secondary sites of infection.
To assess the host inflammatory response to Mtb, the
proinflammatory cytokines IL-1b, TNFa, and IL-6 were mea-
sured from lung homogenates of Nlrp122/2 and wild type mice
(Figure 4E–G). The amount of lung IL-1b increased in both
Nlrp122/2 and wild type mice as Mtb infection progressed. TNFa
and IL-6 levels were also comparable between the lungs of
Nlrp122/2 and wild type mice at one day postinfection and during
the chronic phase of the infection. At day 14, we found that
Nlrp122/2 lungs had reduced TNFa and IL-6 compared to wild
type mice, which approached significance (p = 0.056 and p = 0.06,
respectively). However, the physiological relevance of these
findings is currently unclear and is in contrast to the anti-
inflammatory role previously described for NLRP12 in human
monocytic cell lines. This finding is reminiscent of NLRP3, which
profoundly influences IL-1b production in cultured macrophages
in response to Mtb, but does not significantly influence the in vivo
model [22,34]. Together, these data suggest that NLRP12 does
not significantly affect lung cytokine levels, bacterial burden or
mouse survival in an in vivo model of Mtb infection. Thus, we
conclude that NLRP12 does not play a significant role in
attenuating or exacerbating Mtb infection.
Chronic Mtb infection results in a significant increase in lung
inflammation and the formation of highly structured granulomas.
A diverse array of cytokines has been shown to influence the
formulation and maintenance of Mtb granulomas, including TNFa
and IL-6 [35,36]. These cytokines are important for the innate
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immune response during the initial exposure of the host to Mtb,
but they are also important for regulating the host immune
response during chronic Mtb infection. We observed a trending
decrease in lung TNFa and IL-6 levels in the Nlrp122/2 mice.
Thus, we next sought to evaluate lung histopathology over the
time course of Mtb infection. Lungs were harvested at 14, 26 and
181 days post-infection, which represents the early growth phase,
the entry to the persistence phase and the chronic phase of Mtb
infection in C57Bl/6 mice, respectively [24]. Lung sections at
each time point were evaluated and histopathological features
were scored. As seen in Figure 5A, we observed significant
changes in lung histopathology over the time course of the
infection. During the early stages of the infection (Day 14),
neutrophilic infiltration was concentrated around the vasculature
(Figure 5B). However, as the disease progressed, we observed
increased areas of concentrated immune cells throughout the lung
parenchyma, which is indicative of granuloma lesions (Figure 5B).
No significant differences in lung inflammation were observed
between Nlrp122/2 and wild type animals. In addition to
assessments of inflammation, paraffin embedded lung sections
were stained with Ziehl-Neelsen acid fast stain to identify Mtb in
situ. Our earlier data suggested that the overall lung bacterial
burden was unaffected by the loss of NLRP12 (Figure 4B).
Consistent with these earlier findings, we did not detect any
differences in the bacteria burden or bacterial localization in the
Nlrp122/2 and wild type mice, shown by acid-fast staining for Mtb
Figure 4. NLRP12 is not protective during Mtb infection. A) Nlrp122/2 mice infected with Mtb had no difference in survival compared to wild
type mice (median survival was 217 days and 220 days, respectively). B–D) Bacterial burden in the lungs, liver, and spleen was comparable between
Nlrp122/2 and wild type mice at all time points assessed. E) Similar amounts of IL-1b were observed in whole lung homogenates from Nlrp122/2
mice compared to wild-type lungs during both early and chronic phases of Mtb infection. F–G. Cytokine measurements of TNFa (F) and IL-6 (G)
showed that Nlrp122/2 and wild-type lungs had similar amounts of cytokines at one day post-infection and during chronic Mtb infection. At 14 days
post-infection, Nlrp122/2 lungs had reduced cytokines compared to wild-type lungs that neared significance (p = 0.056 and p = 0.06, respectively).
Bacteria burden and cytokine measurements at each time point were taken from 3 mice per genotype per time point. Nlrp122/2, n = 19; Wild type,
n = 17; Experiments were repeated 2 separate times with a minimum of 12 Mtb infected Nlrp122/2 and wild type mice in each group. At least 3 mice
per strain per time-point were used for CFU and cytokine assessments.
doi:10.1371/journal.pone.0060842.g004
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Figure 5. Lung histopathology and Mtb granuloma formation is unaltered in Nlrp12 deficient mice. Histopathological analyses of lung
sections were conducted at 14, 26 and 181 days post infection (DPI) with aerosol Mtb. A) Semiquantative histology scoring revealed a similar increase
in lung inflammation over the course of the Mtb infection between Nlrp122/2 and wild type mice. B) Histopathological progression of leukocyte
infiltration at 14, 26 and 181 DPI. Mild to moderate perivascular cuffing was observed around the vasculature of the lungs by 14 DPI. Extensive
leukocyte infiltration around the vasculature, airways and throughout the lung parachema was observed by 26 DPI. Large, well formed granulomas
were observed at 181 days post infection, which affected extensive regions of the lungs. No signs of abnormal inflammation or granuloma formation
were detected in the saline treated mice at any time point evaluated. The magnification bar at 206= 10 mM and 406= 5 mM. C) Images from acid fast
stained lung sections revealed that the leukocyte infiltration was associated with concentrated areas of bacteria infiltration and was consistent with
early stage granuloma formation. The magnification bar at 606= 5 mM. D–E) The number of granulomas per lung and the size of each granuloma
was determined and no significant differences in granuloma formation was observed between either Nlrp122/2 or wild type mice. Experiments were
repeated 2 separate times with a minimum of 12 Mtb infected Nlrp122/2 and 12 wild type mice in each group. At least 3 mice per strain per time-
point were used for analysis.
doi:10.1371/journal.pone.0060842.g005
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bacilli (Figure 5C). In all cases, the majority of the bacteria were
associated with the granulomas. We also characterized the
granulomas in each lung section as previously described [22]. As
shown in Figure 5D–E, the number of granulomas observed per
lung and the average size of the granulomas were not significantly
different between the Nlrp122/2 and wild type mice. Together,
these data demonstrate that the host response to Mtb, including
granuloma formation and maintenance, are unaffected by the loss
of NLRP12.
Discussion
Several NLRs have been shown to negatively regulate NF-kB
signaling [7,8,9,10,11,12,13]. Of these NLRs, NLRP12 is the
prototypical member and has been shown to negatively regulate
components of both canonical and non-canonical NF-kB path-
ways in vitro and more recently found to display this role in vivo in
colitis and colon cancer models [14,16]. The canonical NF-kB
signaling pathway is a critical modulator of innate immunity and is
essential for host protection against pulmonary K. pneumoniae and
Mtb infection [31,37,38]. While components of the non-canonical
NF-kB and NIK signaling pathways have not been directly
evaluated in the context of K. pneumoniae or Mtb infection, LPS
from Salmonella enterica has been shown to activate both canonical
and non-canonical NF-kB signaling pathways [39]. Likewise, NIK
deficient aly/aly mice have demonstrated protection in LPS models
of bone resorption and osteoclastogenesis [40]. Thus, elements of
the non-canonical pathway likely influence host innate immunity
to several gram negative bacteria species in vivo.
NLRP12 has been previously shown in vitro to function as a
negative regulator of the host innate immune response to both
LPS and MTb in human THP-1 monocytic cell lines [10,12]. This
function was shown to be associated with the ability of NLRP12 to
interfere with both TLR2 and TLR4 pathways and antagonize
signaling events downstream of MyD88, IRAK-1, TRAF2,
TRAF6 and RIP1. The mechanism associated with this attenu-
ation was attributed to the inhibition of IRAK-1 hyper-
phosphyorylation [10]. While these initial studies were essential
for the characterization of NLRP12, the physiological relevance of
this NLR in infectious diseases is unclear. The previous studies
were all conducted in vitro and utilized cultured human cell lines
[10,11,12,26]. Recent studies have begun to examine the in vivo
role of NLRP12 utilizing Nlrp122/2 mice. In studies evaluating the
development of allergic airway inflammation, no significant
differences were observed between Nlrp122/2 mice and wild type
animals [41]. However, NLRP12 was shown to influence the
development of contact hypersensitivity and colitis associated
cancer, which are both disease models with a strong innate
immune system component. In the contact hypersensitivity
models, dendritic cells and neutrophils from Nlrp122/2 mice
failed to respond to select chemokines, which resulted in reduced
migration and attenuated disease progression [15]. However, in
models of experimental colitis and tumorigenesis, Nlrp122/2 mice
demonstrated significantly increased inflammation and cancer
progression associated with reduced inhibition of NF-kB signaling
[14,16]. Thus, it appears that NLRP12 displays distinct tissue- and
disease-specific functions in vivo. Together, the previous in vitro
findings and the in vivo data associated with the innate immune
response suggested that the Nlrp122/2 mice would serve as an
appropriate model to evaluate disease pathogenesis during
bacterial pneumonia and Mtb infection. However, as our data
shows, we were unable to identify a functional role for NLRP12 in
either disease.
Together, these data demonstrate the importance of validating
findings from cell culture/cell lines to mouse models. This is
especially evident in the Mtb findings, which showed a convinc-
ingly strong in vitro phenotype for NLRP12 that was not apparent
in our in vivo experiments. Likewise, previous in vitro data suggested
that we would observe a significant in vivo phenotype in the
Nlrp122/2 mice following LPS stimulation and K. pneumoniae
infection, which we did not observe in our current study. Similar
disconnects have been observed between the in vitro data and
in vivo data for several NLRs and inflammasome adaptor proteins.
For example, recent reports utilizing human cell lines and primary
cells from knockout mice reported that components of the NLRP3
inflammasome were necessary for the host immune response
against MTb infection [22,42,43]. However, follow-up studies
utilizing Nlrp32/2 and Caspase-12/2 mice revealed that these
inflammasome components did not directly affect the host
immune response to in vivo Mtb infection [22,34,44]. Thus, many
NLRs, including NLRP12, likely function through unpredictable
mechanisms in the complex in vivo environment.
The most likely explanation for the discrepancy between the
previous in vitro findings for NLRP12 and the data presented here,
which suggest that NLRP12 does not significantly contribute to
the in vivo host innate immune response to the pathogens
evaluated, is that the studies are fundamentally different (i.e.
in vivo vs. in vitro; human vs. mouse). However, it is possible that
NLRP12 does contribute to the host innate immune response in a
temporal, cell type-, tissue-, dose- or PAMP-specific manner and
the models utilized here were too broad to discern its function.
This hypothesis is supported by other findings that have shown
differential and transient expression of NLRP12 in human and
rodent cells [10,15,45]. Of particular relevance to the current
work, NLRP12 was shown to be significantly elevated in cells
collected from the BALF of rats that were challenged in vivo with
either silica particles or LPS [45]. However, this up-regulation was
shown to be transient, temporal and PAMP/DAMP specific [45].
The in vivo bacteria models utilized in the current study are
associated with robust immune responses, which may obscure the
contribution of indirect or subtle regulators of innate immunity.
Thus, it is possible that the in vivo contribution of NLRP12 may
have been obscured by the high levels of inflammation, which was
not a factor in the previous contact hypersensitivity study [15]. In
an attempt to circumvent this issue, we utilized LPS as a less
robust, bacteria-free model to assess the innate immune response.
However, similar to the bacteria studies, we also failed to detect a
significant role for NLRP12. It is certainly possible that other
in vivo models, which combine lower levels of inflammation with
higher resolution analyses, may reveal a role for NLRP12 in
mediating the innate immune response to pathogens. For example,
a recent study showed a role for NLRP12 in inflammasome
formation and IL-1b/IL-18 maturation in response to a subcu-
taneous infection with a genetically attenuated strain of Yersinia,
but not other activators that engage the NLRP3 inflammasome
[27]. Thus, it appears that the inflammasome function of NLRP12
is spatial and/or pathogen specific.
A second possible explanation for the discordance between the
in vitro and in vivo findings is that other genes may be compensating
for the loss of NLRP12 in vivo. Several recent papers have
identified other NLRs that function as negative regulators of
canonical and noncanonical NF-kB signaling, many of which may
be capable of compensating for the loss of NLRP12. For example,
NLRC5 has been shown to attenuate NF-kB signaling following
in vitro PAMP stimulation [46,47]. NLRC5 has also been suggested
to inhibit NF-kB signaling through its interaction with IKKa and
IKKb [47,48], although controversy exists regarding its negative
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regulatory function [49]. In addition to members of the NLR
family, the NF-kB pathway is highly regulated, both positively and
negatively, by a large assortment of other proteins. Thus, it is
possible that some additional negative regulators may function,
either up-stream or down-stream, to compensate for the loss of
NLRP12 activity during lung inflammation.
Our data suggests that NLRP12 does not contribute to host
defense in response to a limited selection of PAMPs and
pathogens. However, it should be noted that future in vivo
assessments in the lung or in other tissues using other model
systems may discern novel functions for NLRP12 in mediating
innate immunity. Here, we assessed the role of NLRP12 in acute
and chronic models of bacterial pneumonia and Mtb infection.
Each of these diseases impact a growing number of humans world
wide and it is essential that we expand our understanding of the
underlying disease mechanisms associated with the host immune
response in each of these cases. The lack of a role for NLRP12 in
the disease processes assessed here is encouraging from the aspect
of pharmacological inhibitors that target other inflammatory
disorders, such as contact hypersensitivity or inflammatory bowel
disease, where NLRP12 was found to play a role in a disease
model.
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